SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-764370
Filing Date
2016-11-09
Accepted
2016-11-09 16:16:58
Documents
49
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d247783d10q.htm 10-Q 381962
2 EX-10.1 d247783dex101.htm EX-10.1 7807
3 EX-10.2 d247783dex102.htm EX-10.2 7792
4 EX-10.3 d247783dex103.htm EX-10.3 7809
5 EX-31.1 d247783dex311.htm EX-31.1 6406
6 EX-31.2 d247783dex312.htm EX-31.2 6450
7 EX-32 d247783dex32.htm EX-32 4544
  Complete submission text file 0001193125-16-764370.txt   2825249

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT itci-20160930.xml EX-101.INS 547197
9 XBRL TAXONOMY EXTENSION SCHEMA itci-20160930.xsd EX-101.SCH 27785
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20160930_cal.xml EX-101.CAL 42660
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20160930_def.xml EX-101.DEF 100629
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20160930_lab.xml EX-101.LAB 276569
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20160930_pre.xml EX-101.PRE 194874
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 161984458
SIC: 2834 Pharmaceutical Preparations